ICANEWS

Glucosamine Use Linked to Accelerated Cognitive Decline in Alzheimer's Progression

ScienceDaily Mind · · 1 min read · Humanities

Read research and analysis on Glucosamine Use Linked to Accelerated Cognitive Decline in Alzheimer's Progression published by ICANEWS, a global research journal for emerging researchers.

Key Takeaways

  • Glucosamine use was associated with a 25% higher likelihood of mild cognitive impairment progressing to dementia.
  • Lab experiments suggested glucosamine may intensify an abnormal sugar-tagging process in the Alzheimer’s brain.

Why This Matters

The study suggests a potential link between a common joint supplement and accelerated cognitive decline in individuals with mild cognitive impairment. This highlights a need for further investigation into the safety of glucosamine for this specific population.

Overview

Research involving a large health-record analysis and lab experiments investigated the relationship between glucosamine use and Alzheimer’s disease progression. The health-record analysis indicated an association between glucosamine use and an increased likelihood of mild cognitive impairment (MCI) advancing to dementia. Concurrently, laboratory experiments suggested a potential mechanism involving the intensification of an abnormal sugar-tagging process within the Alzheimer’s brain.

Research Context

Glucosamine is a widely used joint supplement. The study focused on its potential impact on the progression of Alzheimer's disease, specifically examining the transition from mild cognitive impairment to dementia. The investigation also included experimental work to explore potential biological mechanisms underlying any observed associations.

Approach

The study employed a dual approach: a large-scale analysis of health records and laboratory experiments. The health-record analysis involved a cohort of individuals to assess the statistical association between glucosamine use and the progression from MCI to dementia. The laboratory experiments aimed to explore cellular and molecular processes, specifically an abnormal sugar-tagging process, within the context of Alzheimer's disease in relation to glucosamine.

Findings

  • The health-record analysis indicated that glucosamine use was associated with a 25% higher likelihood of mild cognitive impairment progressing to dementia.
  • Laboratory experiments suggested that the popular joint supplement may intensify an abnormal sugar-tagging process in the Alzheimer’s brain.

Why This Matters

The findings suggest a potential link between a widely used over-the-counter supplement and accelerated cognitive decline in individuals with mild cognitive impairment. This raises questions about the use of glucosamine in a population susceptible to Alzheimer’s progression.

Key Limitations Mentioned by Researchers

Researchers stated that clinical trials are needed to determine whether glucosamine actually causes harm.

Research Information

Institution
ScienceDaily Mind
Original Study
View Publication
Source
ScienceDaily Mind

About ICANEWS

ICANEWS is a global research journal for emerging researchers, publishing student and emerging researcher work across all fields.